Alzheimer's Disease

Causes and Risk Factors

Causes Not Fully Understood

Scientists do not yet fully understand what causes Alzheimer's disease. It is likely that the causes include some mix of genetic, environmental, and lifestyle factors. These factors affect each person differently.

Research shows that Alzheimer’s disease causes changes in the brain years and even decades before the first symptoms appear, so even people who seem free of the disease today may be at risk. Scientists are developing sophisticated tests to help identify who is most likely to develop symptoms of Alzheimer’s. Ultimately, they hope to prevent or delay dementia in these high-risk individuals.

Risk Factors

Some risk factors for Alzheimer’s, like age and genetics, cannot be controlled. Other factors that may play a role in the development of the disease—such as how much a person exercises or socializes—can be changed.

Lifestyle factors, such as diet and physical exercise, and long-term health conditions, like high blood pressure and diabetes, might also play a role in the risk of developing Alzheimer’s disease. For more information, see the chapter entitled “Prevention.”

Older Age—The Biggest Risk Factor

Increasing age is the most important known risk factor for Alzheimer's disease. The number of people with the disease doubles every 5 years beyond age 65. Nearly half of people age 85 and older may have Alzheimer’s. These facts are significant because the number of older adults is growing.

Genetics

There are two types of Alzheimer’s disease—early-onset and late-onset.

Many studies have linked the apolipoprotein E gene to late-onset Alzheimer’s. One form of this gene, APOE ɛ4, increases a person’s risk of getting the disease. But many people who get Alzheimer’s do not have the APOE ɛ4 gene, and some people with the gene never get Alzheimer’s.

Scientists have identified a number of other genes in addition to APOE ɛ4 that may increase a person’s risk for late-onset Alzheimer’s. Knowing about these genes can help researchers more effectively test possible treatments and prevention strategies in people who are at risk of developing Alzheimer’s -- ideally, before symptoms appear.